Covid: Government panel recommends permission for phase-3 trial of Covovax as booster dose in adults
It has been approved by the European Medicines Agency for conditional marketing authorisation and has also been granted emergency use listing by WHO
Stay updated with breaking news from Sputnik Light. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It has been approved by the European Medicines Agency for conditional marketing authorisation and has also been granted emergency use listing by WHO
The milder Omicron variant raises hope that we can perhaps tame the pandemic. It is the unvaccinated who may usher in a fresh wave - Issue Date: Mar 14, 2022
The DCGI had on February 4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions, , Sputnik Light Vaccine, Sputnik Light
Kazakhstan becomes the first country outside Russia to authorize Sputnik M vaccine for adolescents | Official website vaccine against coronavirus Sputnik V.
NEW DELHI, Mar 5: An expert panel of India’s central drug authority has recommended the permission for conducting phase-3 clinical trial of single-dose COVID-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. The DCGI had on February 4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions. Hyderabad-based Dr. Reddy’s Laboratories had presented its […]